Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2022-02-17
Product name
HYCAMTIN INJECTABLE
Product Synonyms
HYCAMTIN INFUSION 1 MG/3 ML * HYCAMTIN INJECTION 1 MG/3 ML * HYCAMTIN INJECTION 4 MG/5 ML * HYCAMTIN INJECTION (CONTAINING 10% TOPOTECAN) * TOPOTECAN, FORMULATED PRODUCT
Emergency telephone
+(1) 760 476 3971, +(1) 760 476 3962
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H300, H318, H340, H350, H360, H370
Hazard statements
Code
Statements
H300
Fatal if swallowed
Section 2
SECTION 2: Hazards identification
Physical hazards
Not classified
Health hazards
Acute toxicity, oral Category 2 Serious eye damage/eye irritation Category 1 Germ cell mutagenicity Category 1 Carcinogenicity Category 1B Reproductive toxicity Category 1B Specific target organ toxicity, single exposure Category 1
Environmental hazards
Not classified
Signal word
Danger
Hazard statements
Fatal if swallowed. Causes serious eye damage. May cause genetic defects. May cause cancer. May damage fertility or the unborn child. Causes damage to organs.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapors/spray. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Wear protective gloves/protective clothing/eye protection/face protection.
Response
If swallowed Immediately call a poison center/doctor/. Rinse mouth. If in eyes Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a poison center/doctor/. Take off contaminated clothing and wash it before reuse.
Storage
Store locked up.
Disposal
Dispose of contents/container to . Hazard(s) not otherwise Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health classified (HNOC) hazards
Additional information
10% of the mixture consists of component(s) of unknown acute dermal toxicity.
2.1 Classification of the substance or mixture
Not classified. Health hazards Acute toxicity, oral Category 2 Serious eye damage/eye irritation Category 1 Germ cell mutagenicity Category 1 Carcinogenicity Category 1B Reproductive toxicity Category 1B Specific target organ toxicity, single exposure Category 1 Environmental hazards Not classified. OSHA defined hazards Not classified.
